MNMD - Total Utang marang Modal Mind Medicine Corp

Logo perusahaan publik Mind Medicine (MNMD)

How should complex mental disorders be treated? Mind Medicine (MNMD) is developing breakthrough drugs at the intersection of neuroscience. This chart illustrates the debt-to-equity ratio as calculated by the GURU.Markets system, where 0.31 captures the value of this parameter. The solution lies in a future patent monopoly coupled with low production costs, which is further supported by strong investor confidence in the company's innovations.

MNMD: Total Utang marang Modal MindMed 04.07.2022 - 15.01.2026

Rincian analitis perusahaan Mind Medicine

- rega lan prakiraan konsensus rega:
Bagan rega MindMed|MNMD - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar MindMed|MNMD - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham MindMed|MNMD - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku mindmed.co|MNMD - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Mind Medicine|MNMD - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Mind Medicine|MNMD - Gunggung utang perusahaan|Utang marang nilai buku MindMed|MNMD - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan MindMed|Likuiditas cepet mindmed.co
- informasi bathi lan kelipatan valuasi:
MNMD - Asil keuangan resik
Analisis dhasar perusahaan:MindMed
Barang utama Mind Medicine Corp

The financial stability of Mind Medicine (MNMD) is determined by the balance between raised funds and proprietary assets. This metric is calculated as the ratio of total liabilities to equity, reflecting the share of debt financing within the business structure. This coefficient measures the organization's risk of dependence on creditors. For a biotechnology startup without current revenue, this is a critical indicator of solvency. By analyzing the changing proportion of total debt to equity, an investor assesses the probability of a cash crunch prior to the commercialization of drugs.

Analisis pesaing Mind Medicine

Utang marang Ekuitas Alkermes|Avadel Pharmaceuticals PLC - Utang Agregat marang Ekuitas|Total Utang marang Modal ATAI|GHRS (GH Research Group) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal CMPS (COMPASS Pathways plc)|Total Utang marang Modal lbpharma.us LBRX|DRUG - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi VNDA (Vanda Pharma)|cybin.com (CYBN) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Alto Neuroscience Corp|NRXP (NRx Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal Cingulate Corp|Rasio Total Utang marang Ekuitas SILO (Silo Pharma, Inc.)|CPHI (chinapharmaholdings.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Clearmind Medicine CMND|PBM (Psyence Bio) - Utang Agregat marang Ekuitas|SPRC - Utang marang Ekuitas|Koefisien Total Utang marang Modal seelostherapeutics.com SEEL|VRPX (virpaxpharma.com) - Rasio Total Utang marang Ekuitas|Utang marang Modal Karuna Therapeutics Inc (KRTX)